Hugel (XKRX:145020) Change In Receivables : ₩14,900 Mil (TTM As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hugel Change In Receivables?

Hugel's change in receivables for the quarter that ended in Mar. 2024 was ₩17,355 Mil. It means Hugel's Accounts Receivable declined by ₩17,355 Mil from Dec. 2023 to Mar. 2024 .

Hugel's change in receivables for the fiscal year that ended in Dec. 2023 was ₩7,976 Mil. It means Hugel's Accounts Receivable declined by ₩7,976 Mil from Dec. 2022 to Dec. 2023 .

Hugel's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩26,717 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Hugel's Days Sales Outstanding for the three months ended in Mar. 2024 was 32.81.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Hugel's liquidation value for the three months ended in Mar. 2024 was ₩333,098 Mil.

Hugel Change In Receivables Historical Data

The historical data trend for Hugel's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hugel Change In Receivables Chart

Hugel Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

11,227.44

6,159.00

-1,785.40

-26,010.18

7,975.81

Hugel Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															10,429.84	7,669.05	2,010.03	-12,133.12	17,354.51

Hugel Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩14,900 Mil.

Hugel (XKRX:145020) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Hugel's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	26716.868	/	74306.211	*	91
=	32.81

2. In Ben Graham's calculation of liquidation value, Hugel's accounts receivable are only considered to be worth 75% of book value:

Hugel's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	451873.572	-	160789.672	+	0.75 * 26716.868	+	0.5 * 43952.085
=	333,098

Hugel Change In Receivables Related Terms

Thank you for viewing the detailed overview of Hugel's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hugel (XKRX:145020) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206

Website

http://www.hugel.co.kr

Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.

Hugel (XKRX:145020) Headlines

No Headlines